Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members.
Digregorio M, Van Ngoc P, Delogne S, Meyers E, Deschepper E, Duysburgh E, De Rop L, De Burghgraeve T, Coen A, De Clercq N, Sutter A, Verbakel JY, Cools P, Heytens S, Buret L, Scholtes B. Digregorio M, et al. Among authors: de clercq n. Vaccines (Basel). 2022 Apr 12;10(4):598. doi: 10.3390/vaccines10040598. Vaccines (Basel). 2022. PMID: 35455347 Free PMC article.
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
Meyers E, Deschepper E, Duysburgh E, De Rop L, De Burghgraeve T, Van Ngoc P, Digregorio M, Delogne S, Coen A, De Clercq N, Buret L, Coenen S, Sutter A, Scholtes B, Verbakel JY, Cools P, Heytens S. Meyers E, et al. Among authors: de clercq n. Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361. Viruses. 2022. PMID: 36366456 Free PMC article.
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
Meyers E, De Rop L, Deschepper E, Duysburgh E, De Burghgraeve T, Van Ngoc P, Digregorio M, Delogne S, Coen A, De Clercq N, Buret L, Coenen S, De Sutter A, Scholtes B, Verbakel JY, Cools P, Heytens S. Meyers E, et al. Among authors: de clercq n. Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28. Eur J Gen Pract. 2023. PMID: 36440533 Free PMC article.
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.
Digregorio M, Van Ngoc P, Delogne S, Meyers E, Deschepper E, Dardenne N, Duysburgh E, De Rop L, De Burghgraeve T, Coen A, De Clercq N, De Sutter A, Verbakel JY, Cools P, Heytens S, Buret L, Scholtes B. Digregorio M, et al. Among authors: de clercq n. Vaccine X. 2024 Jan 30;16:100453. doi: 10.1016/j.jvacx.2024.100453. eCollection 2024 Jan. Vaccine X. 2024. PMID: 38361529 Free PMC article.
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
McGoldrick M, Gastineau T, Wilkinson D, Campa C, De Clercq N, Mallia-Milanes A, Germay O, Krishnan J, Van Ooij M, Thien MP, Mlynarczyk PJ, Saltus E, Wauters F, Juvin P, Clenet D, Basso A, Dellepiane N, Pagliusi S, Collaço de Moraes Stávale M, Sivaramakrishnan VH, Desai S. McGoldrick M, et al. Among authors: de clercq n. Vaccine. 2022 Feb 23;40(9):1223-1230. doi: 10.1016/j.vaccine.2021.12.038. Vaccine. 2022. PMID: 35180994 Free PMC article. Review.
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk.
Warmbrunn MV, Koopen AM, de Clercq NC, de Groot PF, Kootte RS, Bouter KEC, Ter Horst KW, Hartstra AV, Serlie MJ, Ackermans MT, Soeters MR, van Raalte DH, Davids M, Nieuwdorp M, Groen AK. Warmbrunn MV, et al. Among authors: de clercq nc. Metabolites. 2021 Apr 13;11(4):236. doi: 10.3390/metabo11040236. Metabolites. 2021. PMID: 33924347 Free PMC article.
Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study.
de Clercq NC, van den Ende T, Prodan A, Hemke R, Davids M, Pedersen HK, Nielsen HB, Groen AK, de Vos WM, van Laarhoven HWM, Nieuwdorp M. de Clercq NC, et al. Clin Cancer Res. 2021 Jul 1;27(13):3784-3792. doi: 10.1158/1078-0432.CCR-20-4918. Epub 2021 Apr 21. Clin Cancer Res. 2021. PMID: 33883174 Clinical Trial.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. van den Ende T, et al. Among authors: de clercq nc. Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504550 Clinical Trial.
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers.
Dellepiane N, Pagliusi S, Akut P, Comellas S, De Clercq N, Ghadge S, Gastineau T, McGoldrick M, Nurnaeni I, Scheppler L; Regulatory Experts Working Group. Dellepiane N, et al. Among authors: de clercq n. Vaccine X. 2020 Aug 25;6:100075. doi: 10.1016/j.jvacx.2020.100075. eCollection 2020 Dec 11. Vaccine X. 2020. PMID: 32995745 Free PMC article.
59 results